Nwam LLC purchased a new position in shares of Cabot Corporation (NYSE:CBT – Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 10,220 shares of the specialty chemicals company’s stock, valued at approximately $770,000.
Several other hedge funds and other institutional investors have also recently modified their holdings of CBT. Principal Financial Group Inc. boosted its stake in Cabot by 6.5% in the 1st quarter. Principal Financial Group Inc. now owns 177,368 shares of the specialty chemicals company’s stock worth $13,358,000 after purchasing an additional 10,765 shares in the last quarter. Fifth Third Bancorp raised its holdings in shares of Cabot by 312.5% in the first quarter. Fifth Third Bancorp now owns 49,248 shares of the specialty chemicals company’s stock worth $3,709,000 after buying an additional 37,308 shares during the last quarter. Sequoia Financial Advisors LLC raised its holdings in shares of Cabot by 10.4% in the first quarter. Sequoia Financial Advisors LLC now owns 15,099 shares of the specialty chemicals company’s stock worth $1,137,000 after buying an additional 1,423 shares during the last quarter. SkyOak Wealth LLC acquired a new stake in shares of Cabot during the first quarter worth $256,000. Finally, Appleton Partners Inc. MA acquired a new stake in shares of Cabot during the first quarter worth $223,000. 93.18% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of research analysts have recently weighed in on CBT shares. UBS Group increased their price objective on Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a report on Friday, May 8th. JPMorgan Chase & Co. lifted their price objective on shares of Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a report on Wednesday, May 13th. Truist Financial initiated coverage on Cabot in a research report on Monday, June 8th. They issued a “buy” rating and a $98.00 price objective for the company. Weiss Ratings restated a “hold (c)” rating on shares of Cabot in a research report on Tuesday, May 26th. Finally, Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a report on Sunday, June 14th. Two analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Cabot currently has an average rating of “Hold” and a consensus price target of $85.80.
Cabot Trading Up 1.5%
Shares of CBT opened at $91.21 on Friday. The firm has a 50-day moving average price of $86.21 and a 200 day moving average price of $77.84. The firm has a market capitalization of $4.71 billion, a P/E ratio of 17.24, a P/E/G ratio of 11.82 and a beta of 0.83. The company has a current ratio of 1.45, a quick ratio of 0.96 and a debt-to-equity ratio of 0.51. Cabot Corporation has a 12-month low of $58.33 and a 12-month high of $94.53.
Cabot (NYSE:CBT – Get Free Report) last released its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $1.61 EPS for the quarter, beating analysts’ consensus estimates of $1.47 by $0.14. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The firm had revenue of $904.00 million for the quarter, compared to analysts’ expectations of $900.30 million. During the same period in the prior year, the firm posted $1.90 earnings per share. The firm’s quarterly revenue was down 3.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Sell-side analysts forecast that Cabot Corporation will post 6.34 EPS for the current year.
Cabot Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be paid a $0.4725 dividend. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend is Friday, August 28th. Cabot’s payout ratio is 35.73%.
Cabot Profile
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Recommended Stories
- Five stocks we like better than Cabot
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
